Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)

NCT03102307 · clinicaltrials.gov ↗

COMPLETED

Status

548

Enrollment

OTHER

Sponsor class

Conditions

Early Stage Breast Cancer

Interventions

OTHER: Not suitable for TAD
PROCEDURE: Suitable for TAD

Sponsor

Kliniken Essen-Mitte

Collaborators

[object Object]